Does LAG3 and PD1 inhibition have a role in treating brain metastases in melanoma

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=yhz19e0x1kY

Meredith McKean, MD, Sarah Cannon Research Institute, Nashville, TN, discusses the potential role of fianlimab and cemiplimab, a LAG-3 and PD-1 inhibitor res...

Speaker: Meredith McKean, Institution: Sarah Cannon Research Institute, Event: ESMO 2024, Format: Interview, Subject: Melanoma, Subject: Skin Cancer, Field: Treatment, Field: Perspectives, Field: Immuno-Oncology, Medicines: Antibodies, Medicines: Checkpoint inhibitors, Medicines: Fianlimab, Medicines: Cemiplimab, Medicines: Ipilimumab, Medicines: Nivolumab, LAG-3, brain metastases, PD-1
#############################